https://www.thebodypro.com/author/gay-mens-health-crisis
Gay Men's Health Crisis Img

Gay Men's Health Crisis

Who We Are

GMHC is the world's first and leading provider of HIV/AIDS prevention, care and advocacy. Building on decades of dedication and expertise, we understand the reality of HIV/AIDS and empower a healthy life for all.

Our Mission: GMHC fights to end the AIDS epidemic and uplift the lives of all affected.

What We Believe

  • With the right information, care and support, it is possible to live a healthy, fulfilling life.
  • When people feel a sense of community, are empowered with pride and armed with information, they're able to model healthy behaviors, build relationships and experience hope.
  • To end the AIDS epidemic, we need comprehensive solutions that promote education, increase awareness, improve care, reduce stigma, elevate policy and build strong, supportive communities.

How We Make a Difference

  • Answers that give hope: Whether it's getting tested, living with HIV/AIDS, succeeding at home and work or elevating our voice for policy change, we provide answers that give hope.
  • Care that promotes health: We understand the root causes of the disease and take a holistic approach to care -- from medical treatment and counseling to legal services and job placement -- that promotes total well-being for your whole life.
  • We help you develop meaningful relationships within the GMHC community, receive support and give back to others along the way, so you feel a sense of confidence and pride that empowers your life on your terms.

Why It Matters

AIDS is not over. In fact, awareness is down as new infections are up -- including among women, people of color and men who have sex with men. The roots of the epidemic are wide and deep, from stigma and misinformation to the increasing cost of care. At GMHC, we believe we can end the epidemic by addressing the underlying causes, shifting cultural beliefs and promoting smart behaviors that empower a healthy life for all of us.

Background

In 1981, six gay men united against fear and death from a mysterious disease then referred to as a "gay cancer." They began collecting money from friends for research into this new disease. As the group grew and came to grips with the fact that it was such a crisis for gay men, the name of the organization was created -- Gay Men's Health Crisis.

Fight AIDS. Love Life.

Since before AIDS had a name and until the epidemic is over, GMHC will continue to fight AIDS and love life. To learn more about GMHC or how you can donate, volunteer, tour the agency, or become a client, visit www.gmhc.org, contact us by email, or call 212.367.1000.

How to Reach GMHC

Gay Men's Health Crisis
446 West 33rd Street, New York, NY 10001

Phone: 212.367.1000, 1.800.AIDS.NYC
www.gmhc.org

Latest by Gay Men's Health Crisis

Untangling the Intersection of HIV and Trauma: Why It Matters and What We Can Do Img
News

Untangling the Intersection of HIV and Trauma: Why It Matters and What We Can Do

What is trauma? How does it operate in the lives of those who are HIV positive? And how does it keep more than half of HIV-positive people out of medical care?

Disability and HIV: Eliminating Barriers to Sexual Health Care and Education Img

Disability and HIV: Eliminating Barriers to Sexual Health Care and Education

"Addressing HIV/AIDS among people with disabilities starts with recognizing that all people are sexual, regardless of whether they are living with disabilities," Heather Heldman and Hannah Slater write. In this article, the two discuss some of the ch...

Promo Image
Men Who Have Sex With Men

Couples Voluntary HIV Counseling and Testing for Men Who Have Sex With Men

Couples Voluntary HIV Counseling and Testing (CVCT) is a new HIV prevention intervention for men who have sex with men (MSM) in the U.S.1 CVCT is notable for several reasons: it addresses a critical deficit in HIV prevention interventions for MSM;2 i...

Promo Image

Covalent Vaccination and Catalytic Antibodies: A New Way of Looking at an HIV Vaccine

Introduction

There is global concern regarding HIV drug-resistance, drug toxicity, and increasing drug costs. Many health care professionals believe that eradicating HIV will require development of a vaccine that prevents infection by the virus. Yet...

Promo Image

HIV and Inflammation

Inflammation has become a major concern of HIV medicine in recent years. Experts now recognize that persistent HIV infection leads to long-term immune activation and chronic inflammation, even among people on antiretroviral therapy (ART) with undetec...

Promo Image
News

The Role of ARVs in HIV Prevention: Microbicides and PrEP

Table of Contents

Introduction ARV-Based Microbicides Pre-Exposure Prophylaxis Policy and Programmatic Implications General Drawbacks of Using ARVs as a Preventive Technology Overcoming These Drawbacks and the Way Forward Conclusion Re...

Promo Image
Cancer

Anal Cancer Increasing Among People Living With HIV

Why Screen for Anal Cancer in HIV-Positive Patients?

Anal cancer is emerging as a common non-AIDS defining cancer in HIV-positive people. Anal cancer, like cervical cancer, is caused by infection with high-risk types of human papillomavirus (HPV) --...

Promo Image

Antiretroviral Medications in the Pipeline

Over two years ago, four new antiretrovirals were approved: Two of these introduced new classes of therapy, and two others provided new hope for already resistant viruses. These were added to the 20 existing antiretrovirals and have provided even mor...

Promo Image
Older Adults (Ages 50+)

Aging With Complex Chronic Disease: The Wrinkled Face of AIDS

Table of Contents

Introduction Epidemiology The Changing Spectrum of Disease What Can We Do to Prevent "Premature" Aging We Need a New Way of Assessing Risk Conclusion References

Introduction

People living with HIV taking combination A...

Promo Image

Understanding the Results of RV144, the Thai Prime-Boost AIDS Vaccine Trial

In September 2009 the world learned the initial results of RV144, known as the Thai prime-boost AIDS vaccine trial. This study was the largest AIDS vaccine trial to date, with over 16,000 participants. It evaluated the efficacy of a vaccine regimen c...